Essa Pharmaceuticals | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Trial results

16 April 2025

Mural hits a wall

The company scraps nemvaleukin after the latest failure, of Artistry-6.

Trial results

1 November 2024

Essa terminates an N-terminal journey

After beating "historical" Xtandi masofaniten fails to beat actual Xtandi.

Subscribe to Essa Pharmaceuticals